The use of Ivermectin for the treatment of COVID-19: Panacea or enigma?
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,Epidemiology
Reference59 articles.
1. Ivermectin,‘wonder drug’from Japan: the human use perspective;Crump;Proc Jpn Acad, Ser B,2011
2. Ivermectin as a broad-spectrum host-directed antiviral: the real deal?;Jans;Cells,2020
3. Current therapeutic applications and pharmacokinetic modulations of Ivermectin;Khan Sharun;Vet World,2019
4. Ivermectin: panacea for resource-poor communities?;Ōmura;Trends Parasitol,2014
5. The pharmacokinetics and interactions of Ivermectin in humans—a mini-review;Canga;AAPS J,2008
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Generation of IgG antibodies against Strongyloides stercoralis in mice via immunization with recombinant antigens A133 and Ss-IR;Acta Tropica;2024-03
2. Wastewater surveillance of pharmaceuticals during the COVID-19 pandemic in Mexico City and the Mezquital Valley: A comprehensive environmental risk assessment;Science of The Total Environment;2023-11
3. A guide to COVID ‐19 antiviral therapeutics: a summary and perspective of the antiviral weapons against SARS‐CoV ‐2 infection;The FEBS Journal;2022-11-05
4. Polio returns to the USA: An epidemiological alert;Annals of Medicine & Surgery;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3